Morbidity of Pelvic Lymphadenectomy, Radical Retropubic Prostatectomy and External Radiotherapy in Patients with Localised Prostatic Cancer

REFERENCES

• AdolfssonJ, CarstensenJ and LöwhagenT. Deferred treatment in clinically localised prostatic carcinoma. Br J Urol 1992; 69: 183–187.
   PubMedGoogle Scholar
• BabcockJR and GrayhackJT. Morbidity of pelvic lymphadenectomy. Urology 1979; 13: 483–486.
   PubMed Web of Science ®Google Scholar
• BrausiM and SolowayMS. Progression and complications after external beam radiation therapy for carcinoma of the prostate. Urology 1989; 34: 115–119.
   PubMed Web of Science ®Google Scholar
• BrausiM and SolowayMS. Morbidity of modified pelvic lymphadenectomy and radiotherapy for prostatic cancer. Urology 1991; 37: 297–300.
   PubMed Web of Science ®Google Scholar
• BrendlerCB, CleeveLK, AndersonEE and PaulsonDF. Staging pelvic lymphadenectomy for carcinoma of the prostate: risk versus benefit. J Urol 1980; 124: 849–853.
   PubMed Web of Science ®Google Scholar
• CatalonaWJ and DresnerSM. Nerve-sparing radical prostatectomy: extraprostatic tumor extension and preservation of erectile function. J Urol 1985; 134: 1149–1151.
   PubMed Web of Science ®Google Scholar
• FormanJD, WharamMD, LeeDJ, ZinreichES and OrderSE. Definitive radiotherapy following prostatectomy: results and complications. Int J Rad Oncol Biol Phys 1986; 12: 185–189.
   PubMed Web of Science ®Google Scholar
• GeorgeNJR. Natural history of localised prostatic cancer managed with conservative therapy alone. Lancet 1988; 1: 494–497.
   PubMed Web of Science ®Google Scholar
• GibbonsRP, ColeBS, RichardsonRG et al. Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol 1986; 135: 65–68.
   PubMed Web of Science ®Google Scholar
• GreskovichFJ, ZagarsGK, ShermanNE and JohnsonDE. Complications following external beam radiation therapy for prostate cancer: an analysis of patients treated with and without staging pelvic lymphadenectomy. J Urol 1991; 146: 798–802.
   PubMed Web of Science ®Google Scholar
• HanksGE and DawsonAK. The role of external beam radiation therapy after prostatectomy for prostatic cancer. Cancer 1986; 58: 2406–2410.
   PubMed Web of Science ®Google Scholar
• IgelTC, BarrettDM, SeguraJW, BensonRC and RifeCC. Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy. J Urol 1987; 137: 1189–1191.
   PubMed Web of Science ®Google Scholar
• JacobsonGM, SmithJA SmithStewart Jr. Postoperative radiation therapy for pathological stage C prostate cancer. Int J Rad Oncol Biol Phys 1987; 13: 1021–1024.
   PubMed Web of Science ®Google Scholar
• JohanssonJ-E, AdamiH-O, AnderssonS-O, BergströmR, KrusemoUB and KraazW. Natural history of localised prostatic cancer, a population-based study in 223 untreated patients. Lancet 1989; 1: 799–803.
   PubMed Web of Science ®Google Scholar
• LaiPP, PerezCA, ShapiroSJ and LockettMA. Carcinoma of the prostate stage B and C: lack of influence of duration of radiotherapy on tumor control and treatment morbidity. Int Rad Oncol Biol Phys 1990; 19: 561–568.
   Web of Science ®Google Scholar
• LieskovskiG, SkinnerDG and WeisenburgerT. Pelvic lymphadenectomy in the management of carcinoma of the prostate. J Urol 1980; 124: 635–639.
   PubMed Web of Science ®Google Scholar
• MameghanH, FisherR, MameghanJ, WattWH and TynanA. Bowel complications after radiotherapy for carcinoma of the prostate: the volume effect. Int J Rad Oncol Biol Phys 1990; 18: 315–320.
   PubMed Web of Science ®Google Scholar
• McCulloughDL, McLaughlinAP and GittesRF. Morbidity of pelvic lymphadenectomy and radical prostatectomy for prostatic cancer. J Urol 1977; 117: 206–210.
   PubMed Web of Science ®Google Scholar
• McDowellGC, JohnsonJW, TenneyDM and JohnsonDE. Pelvic lymphadenectomy for staging clinically localized prostatic cancer. Urology 1990; 35: 476–482.
   PubMed Web of Science ®Google Scholar
• McLaughlinAP, SaltzsteinSL, McColloughDL and GittesRF. Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. J Urol 1976; 115: 89–92.
   PubMed Web of Science ®Google Scholar
• MeierR, MarkR, TranL, ColburnG and ParkerR. Postoperative radiation therapy after radical prostatectomy for prostate carcinoma. Cancer 1992; 70: 1960–1966.
   PubMed Web of Science ®Google Scholar
• PaulDB, LoeningSA, NarayanaAS, CulpDA. Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate. J Urol 1983; 129: 1141–1144.
   PubMed Web of Science ®Google Scholar
• PaulsonDF, MoulJW, RobertsonJE and WaltherPJ. Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 1990; 143: 1178–1183.
   PubMedGoogle Scholar
• PaulsonDF, MoulJW and WaltherPJ. Radical prostatecomy for clinical stage T1–2N0M0 prostatic adenocarcinoma: long term results. J Urol 1990; 144: 1180–1184.
   PubMed Web of Science ®Google Scholar
• PaulsonDF and RobertsonCN. Positive margins: is adjunctive radiation therapy indicated? Acta Oncologica 1991; 30: 263–265.
   PubMed Web of Science ®Google Scholar
• PedersenKV and HerderA. Radical retropubic prostatectomy for localised prostatic carcinoma: a clinical and pathological study of 201 cases. Scand J Urol Nephrol 1992; 26: 235–239.
   PubMedGoogle Scholar
• Perez. In: Principles and practice of radiation oncology: Carcinoma of the prostate. JB Lippincott Co 1987: 867–898.
   Google Scholar
• PilepichMV, PerezCA, WalzBJ and ZivnuskaFR. Complications of definitive radiotherapy for carcinoma of the prostate. Int J Rad Oncol Biol Phys 1981; 7: 1341–1348.
   PubMed Web of Science ®Google Scholar
• PilepichMV, KrallJ, GeorgeFW, et al. Treatment-related morbidity in phase III RTOG studies of extended-field irradiation for carcinoma of the prostate. Int J Rad Oncol Biol Phys 1984; 10: 1861–1867.
   PubMed Web of Science ®Google Scholar
• QuinlanDM, EpsteinJI, CarterBS and WalshPC. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 1991; 145: 998–1002.
   PubMed Web of Science ®Google Scholar
• RannikkoS and SaloJO. Radical prostatectomy as treatment of localized prostatic cancer. Scand J Urol Nephrol 1990; 24: 103–107.
   PubMed Web of Science ®Google Scholar
• RitchieAWS, JamesK and deKernionJB. Early postoperative morbidity of total prostatectomy. Br J Urol 1989; 64: 511–515.
   PubMedGoogle Scholar
• ServollE, HalvorsenOJ, HaukaasS and HöisüterPÅ. Radical retropubic prostatectomy: our experience with the first 54 patients. Scand J Urol Nephrol 1992; 26: 231–234.
   PubMed Web of Science ®Google Scholar
• UICC TNM classification of malignant tumours. 3rd ed Geneva: UICC 1978.
   Google Scholar
• WalshPC, LeporH and EgglestonJC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983; 4: 473–485.
   PubMed Web of Science ®Google Scholar
• WalshPC and MostwinJL. Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nervesparing technique. Br J Urol 1984; 56: 694–697.
   PubMedGoogle Scholar
• WalshPC, EpsteinJI and LoweFC. Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle. J Urol 1987; 138: 823–827.
   PubMed Web of Science ®Google Scholar
• WilsonCS, DahlDS and MiddletonRG. Pelvic lymphadenectomy for the staging of apparently localized prostatic cancer. J Urol 1977; 117: 197–201.
   PubMed Web of Science ®Google Scholar